Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matthew Oberley"'
Autor:
Justin J. Kuhlman, Quinn J. Frier, Daniel Sumarriva, Matthew Oberley, Danielle Bolton, Ruby A. Deveras
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1392-1398 (2021)
VHL is a tumor suppressor gene located on chromosome 3 that is classically associated with tumors of the eye and CNS, renal cell carcinoma, and pheochromocytoma. We describe what appears to be the first report of an association between a germline VHL
Externí odkaz:
https://doaj.org/article/aa763ae3f6034609b8ecf8f0f7caf8a9
Autor:
Suha Naffar-Abu Amara, Hendrik J. Kuiken, Laura M. Selfors, Timothy Butler, Marco L. Leung, Cheuk T. Leung, Elaine P. Kuhn, Teodora Kolarova, Carina Hage, Kripa Ganesh, Richard Panayiotou, Rosemary Foster, Bo R. Rueda, Athena Aktipis, Paul Spellman, Tan A. Ince, Joanne Xiu, Matthew Oberley, Zoran Gatalica, Nicholas Navin, Gordon B. Mills, Rodrick T. Bronson, Joan S. Brugge
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Cooperative interactions among tumor cells may have important implications for metastasis. Here, the authors examined the spatio-temporal nature of interactions among clonal populations of ovarian carcinoma cells and found that transient interactions
Externí odkaz:
https://doaj.org/article/ab51ec345ea94a3f92bdbbadd751aa0d
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101093- (2021)
Externí odkaz:
https://doaj.org/article/b0dd846f039647d3b8bf5d1874d731f6
Autor:
Jim Abraham, Amy B. Heimberger, John Marshall, Elisabeth Heath, Joseph Drabick, Anthony Helmstetter, Joanne Xiu, Daniel Magee, Phillip Stafford, Chadi Nabhan, Sourabh Antani, Curtis Johnston, Matthew Oberley, Wolfgang Michael Korn, David Spetzler
Publikováno v:
Translational Oncology, Vol 14, Iss 3, Pp 101016- (2021)
Cancer of Unknown Primary (CUP) occurs in 3–5% of patients when standard histological diagnostic tests are unable to determine the origin of metastatic cancer. Typically, a CUP diagnosis is treated empirically and has very poor outcomes, with media
Externí odkaz:
https://doaj.org/article/469bb8ab092d4f4b969ca0049de6630e
Autor:
Rani Bansal, Julie McGrath, Phil Walker, Matias A. Bustos, Estelamari Rodriguez, Sarah L. Sammons, Melissa K. Accordino, Jane Meisel, Margaret Gatti-Mays, Emily Hsu, Kate I. Lathrop, Virginia Kaklamani, Matthew Oberley, W. Michael Korn, Stephanie L. Graff
Publikováno v:
Cancer Research. 83:HER2-12
Introduction: Breast cancer has pioneered precision medicine with prognostic and predictive subtypes, defined by immunohistochemistry (IHC). Novel therapeutic strategies have led to the emergence of HER2-Low (H2L) as a new entity, defined as tumors w
Autor:
Jingyuan Wang, Joanne Xiu, Alex Farrell, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin, Natsuko Kawanishi, Shivani Soni, Wu Zhang, Joshua Millstein, Anthony F Shields, Axel Grothey, Benjamin A Weinberg, John L Marshall, Emil Lou, Moh'd Khushman, Davendra P S Sohal, Michael J Hall, Tianshu Liu, Matthew Oberley, David Spetzler, W Michael Korn, Lin Shen, Heinz-Josef Lenz
Publikováno v:
The Lancet Oncology. 24:151-161
Autor:
Logan Corey, John J. Wallbillich, Sharon Wu, Alex Farrell, Kurt Hodges, Joanne Xiu, Chadi Nabhan, Anthony Guastella, Mira Kheil, Radhika Gogoi, Ira Winer, Sudeshna Bandyopadhyay, Marilyn Huang, Nathaniel Jones, Annelise Wilhite, Anthony Karnezis, Premal Thaker, Thomas J. Herzog, Matthew Oberley, William Michael Korn, Alex Vezina, Robert Morris, Rouba Ali-Fehmi
Publikováno v:
International Journal of Gynecological Pathology.
Autor:
Jeffrey Jean, Alexandra E. Kovach, Andrew Doan, Matthew Oberley, Jianling Ji, Ryan J. Schmidt, Jaclyn A. Biegel, Deepa Bhojwani, Gordana Raca
Publikováno v:
Blood Advances. 6:3343-3346
Autor:
Emil Lou, Nishant Gandhi, Alex Farrell, Joanne Xiu, Andreas Seeber, Beg Muhammad Shaalan, Sourat Darabi, Demeure Michael J., Jim Abraham, Matthew Oberley, John Marshall, Heloisa Soares
Publikováno v:
Endocrine Abstracts.
Autor:
Daniel F. Hayes, Roy S. Herbst, Jonathan L. Myles, Suzanne L. Topalian, Sophia L. Yohe, Naomi Aronson, Andrew M. Bellizzi, Upal Basu Roy, Georganne Bradshaw, Robin H. Edwards, Ehab A. El-Gabry, Julia Elvin, Thomas F. Gajewski, Lisa M. McShane, Matthew Oberley, Reena Philip, David L. Rimm, Jason N. Rosenbaum, Eric H. Rubin, Lisa Schlager, Shimere W. Sherwood, Mark Stewart, Janis M. Taube, Magdalena Thurin, Patricia Vasalos, Jordan Laser
Publikováno v:
JCO precision oncology. 6
PURPOSE Immune checkpoint inhibition (ICI) therapy represents one of the great advances in the field of oncology, highlighted by the Nobel Prize in 2018. Multiple predictive biomarkers for ICI benefit have been proposed. These include assessment of p